Therapeutic Proteins: Developments, Progress, Challenges, and Future Perspectives

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2024 Mar 21

PMID 38510462

Authors

Vimal Kumar

Arti Barwal

Nitin Sharma

Danish Shafi Mir

Pradeep Kumar

Vikas Kumar

Affiliations

Soon will be listed here.

Abstract

Proteins are considered magic molecules due to their enormous applications in the health sector. Over the past few decades, therapeutic proteins have emerged as a promising treatment option for various diseases, particularly cancer, cardiovascular disease, diabetes, and others. The formulation of protein-based therapies is a major area of research, however, a few factors still hinder the large-scale production of these therapeutic products, such as stability, heterogenicity, immunogenicity, high cost of production, etc. This review provides comprehensive information on various sources and production of therapeutic proteins. The review also summarizes the challenges currently faced by scientists while developing protein-based therapeutics, along with possible solutions. It can be concluded that these proteins can be used in combination with small molecular drugs to give synergistic benefits in the future.

Citing Articles

Therapeutic Potential and Mechanistic Insights of a Novel Synthetic α-Lactalbumin-Derived Peptide for the Treatment of Liver Fibrosis.

Maher S, Atta S, Kamel M, Hammam O, Okasha H J Clin Exp Hepatol. 2025; 15(3):102488.

PMID: 39868009 PMC: 11755051. DOI: 10.1016/j.jceh.2024.102488.

Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fraction.

Alvino V, Slater S, Qiu Y, Cattaneo M, Mohammed K, Gate S Cardiovasc Diabetol. 2024; 23(1):397.

PMID: 39501278 PMC: 11536962. DOI: 10.1186/s12933-024-02487-6.

References

Jesuraj S, Sarker M, Ming L, Praya S, Ravikumar M, Wui W . Enhancement of the production of L-glutaminase, an anticancer enzyme, from Aeromonas veronii by adaptive and induced mutation techniques. PLoS One. 2017; 12(8):e0181745. PMC: 5558970. DOI: 10.1371/journal.pone.0181745. View

Kumar D, Batra J, Komives C, Rathore A . QbD Based Media Development for the Production of Fab Fragments in . Bioengineering (Basel). 2019; 6(2). PMC: 6631317. DOI: 10.3390/bioengineering6020029. View

Schillberg S, Raven N, Spiegel H, Rasche S, Buntru M . Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins. Front Plant Sci. 2019; 10:720. PMC: 6579924. DOI: 10.3389/fpls.2019.00720. View

Vandermies M, Fickers P . Bioreactor-Scale Strategies for the Production of Recombinant Protein in the Yeast . Microorganisms. 2019; 7(2). PMC: 6406515. DOI: 10.3390/microorganisms7020040. View

Specht E, Mayfield S . Algae-based oral recombinant vaccines. Front Microbiol. 2014; 5:60. PMC: 3925837. DOI: 10.3389/fmicb.2014.00060. View

Valderrama-Rincon J, Fisher A, Merritt J, Fan Y, Reading C, Chhiba K . An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol. 2012; 8(5):434-6. PMC: 3449280. DOI: 10.1038/nchembio.921. View

Raab N, Mathias S, Alt K, Handrick R, Fischer S, Schmieder V . CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines. Biotechnol J. 2019; 14(5):e1800477. DOI: 10.1002/biot.201800477. View

Bozzacco L, Yu H, Zebroski H, Dengjel J, Deng H, Mojsov S . Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res. 2011; 10(11):5016-30. PMC: 3270889. DOI: 10.1021/pr200503g. View

Dehghani J, Adibkia K, Movafeghi A, Pourseif M, Omidi Y . Designing a new generation of expression toolkits for engineering of green microalgae; robust production of human interleukin-2. Bioimpacts. 2020; 10(4):259-268. PMC: 7502910. DOI: 10.34172/bi.2020.33. View

10.

Yuen K, Johannsson G, Ho K, Miller B, Bergada I, Rogol A . Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis. Endocr Connect. 2023; 12(7). PMC: 10305501. DOI: 10.1530/EC-22-0504. View

11.

Nunberg J, Meade J, Cole G, Lawyer F, McCabe P, Schweickart V . Molecular cloning and characterization of the glucoamylase gene of Aspergillus awamori. Mol Cell Biol. 1984; 4(11):2306-15. PMC: 369059. DOI: 10.1128/mcb.4.11.2306-2315.1984. View

12.

Gaidukov L, Wroblewska L, Teague B, Nelson T, Zhang X, Liu Y . A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Res. 2018; 46(8):4072-4086. PMC: 5934685. DOI: 10.1093/nar/gky216. View

13.

Robinson S, Safavi-Hemami H, McIntosh L, Purcell A, Norton R, Papenfuss A . Diversity of conotoxin gene superfamilies in the venomous snail, Conus victoriae. PLoS One. 2014; 9(2):e87648. PMC: 3914837. DOI: 10.1371/journal.pone.0087648. View

14.

Saraya R, Gidijala L, Veenhuis M, van der Klei I . Tools for genetic engineering of the yeast Hansenula polymorpha. Methods Mol Biol. 2014; 1152:43-62. DOI: 10.1007/978-1-4939-0563-8_3. View

15.

Manuell A, Beligni M, Elder J, Siefker D, Tran M, Weber A . Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol J. 2007; 5(3):402-12. DOI: 10.1111/j.1467-7652.2007.00249.x. View

16.

Kim H, Kim J . A guide to genome engineering with programmable nucleases. Nat Rev Genet. 2014; 15(5):321-34. DOI: 10.1038/nrg3686. View

17.

Nakar C, Shapiro A . Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time. Transfus Apher Sci. 2019; 58(5):578-589. DOI: 10.1016/j.transci.2019.08.008. View

18.

Wang Y, Zhao S, Bai L, Fan J, Liu E . Expression systems and species used for transgenic animal bioreactors. Biomed Res Int. 2013; 2013:580463. PMC: 3613084. DOI: 10.1155/2013/580463. View

19.

Ghaderi D, Taylor R, Padler-Karavani V, Diaz S, Varki A . Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol. 2010; 28(8):863-7. PMC: 3077421. DOI: 10.1038/nbt.1651. View

20.

Celinska E, Borkowska M, Bialas W . Evaluation of heterologous α-amylase production in two expression platforms dedicated for Yarrowia lipolytica: commercial Po1g-pYLSC (php4d) and custom-made A18-pYLTEF (pTEF). Yeast. 2015; 33(5):165-81. DOI: 10.1002/yea.3149. View